As competitive as the obesity drug market has become, Novo Nordisk's decision to slash the prices of its GLP-1 agonist drugs ...
A more than 35% rally in the company's stock this year has largely been driven by the explosive growth of the weight-loss ...
Shares of Lilly rose as much as 1.7% on Friday, pushing its market value to about $1 trillion, according to data compiled by ...
MiBolsilloColombia on MSN
Eli Lilly Hits $1 Trillion Value: How Weight-Loss Drugs Are Reshaping the Stock Market
Eli Lilly briefly became the first healthcare company to reach a $1 trillion market value, fueled by its blockbuster ...
This latest corporate clash has Alkermes working to beat back a challenge from H. Lundbeck for sleep disorder drug developer Avadel Pharmaceuticals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback